Clearstead Advisors, LLC Johnson & Johnson Transaction History

Clearstead Advisors, LLC

$6.31 Billion
Q3 2024

A detailed history of Clearstead Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Clearstead Advisors, LLC holds 238,514 shares of JNJ stock, worth $34.3 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

238,514

Previous 239,161 0.27%

Holding current value

$34.3 Million

Previous $35 Million 10.58%

% of portfolio

0.61%

Previous 0.6%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$145.48 - $167.38 $94,125 - $108,294	-647 Reduced 0.27%	238,514 $38.7 Million
Q2 2024 Aug 09, 2024	BUY	$144.38 - $157.78 $22.7 Million - $24.9 Million	157,566 Added 193.11%	239,161 $35 Million
Q1 2024 May 14, 2024	SELL	$155.22 - $162.74 $318,201 - $333,617	-2,050 Reduced 2.45%	81,595 $12.9 Million
Q4 2023 Feb 12, 2024	BUY	$145.6 - $158.88 $28,683 - $31,299	197 Added 0.24%	83,645 $13.1 Million
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $2.11 Million - $2.37 Million	-13,558 Reduced 13.98%	83,448 $13 Million
Q3 2023 Nov 07, 2023	BUY	$155.75 - $174.48 $2.55 Million - $2.85 Million	16,357 Added 20.28%	97,006 $15.1 Million
Q2 2023 Aug 07, 2023	BUY	$154.35 - $166.11 $2.94 Million - $3.16 Million	19,032 Added 30.89%	80,649 $13.3 Million
Q1 2023 May 09, 2023	BUY	$151.05 - $180.26 $215,548 - $257,231	1,427 Added 2.37%	61,617 $9.55 Million
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $154,112 - $172,957	962 Added 1.62%	60,190 $10.6 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $1.65 Million - $1.83 Million	-10,213 Reduced 14.71%	59,228 $9.68 Million
Q2 2022 Aug 12, 2022	BUY	$168.19 - $186.01 $274,654 - $303,754	1,633 Added 2.41%	69,441 $12.3 Million
Q1 2022 May 04, 2022	BUY	$158.14 - $179.59 $349,014 - $396,355	2,207 Added 3.36%	67,808 $12 Million
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $437,695 - $485,639	2,807 Added 4.47%	65,601 $11.2 Million
Q3 2021 Nov 12, 2021	SELL	$161.5 - $179.47 $112,565 - $125,090	-697 Reduced 1.1%	62,794 $10.1 Million
Q2 2021 Aug 12, 2021	BUY	$159.48 - $171.07 $539,361 - $578,558	3,382 Added 5.63%	63,491 $10.5 Million
Q1 2021 May 14, 2021	BUY	$153.07 - $170.48 $430,892 - $479,901	2,815 Added 4.91%	60,109 $9.88 Million
Q4 2020 Feb 11, 2021	BUY	$137.11 - $157.38 $1.26 Million - $1.44 Million	9,162 Added 19.04%	57,294 $9.02 Million
Q3 2020 Nov 12, 2020	SELL	$140.38 - $153.83 $105,425 - $115,526	-751 Reduced 1.54%	48,132 $7.17 Million
Q2 2020 Aug 11, 2020	BUY	$128.81 - $155.51 $109,102 - $131,716	847 Added 1.76%	48,883 $6.87 Million
Q1 2020 May 14, 2020	SELL	$111.14 - $153.99 $206,053 - $285,497	-1,854 Reduced 3.72%	48,036 $6.3 Million
Q4 2019 Feb 11, 2020	BUY	$127.5 - $146.44 $111,562 - $128,135	875 Added 1.79%	49,890 $7.28 Million
Q3 2019 Nov 12, 2019	SELL	$126.95 - $142.14 $110,065 - $123,235	-867 Reduced 1.74%	49,015 $6.34 Million
Q2 2019 Aug 08, 2019	BUY	$131.15 - $144.24 $200,003 - $219,966	1,525 Added 3.15%	49,882 $6.95 Million
Q1 2019 May 14, 2019	BUY	$125.72 - $139.79 $157,527 - $175,156	1,253 Added 2.66%	48,357 $6.76 Million
Q4 2018 Feb 11, 2019	BUY	$122.84 - $147.84 $619,604 - $745,704	5,044 Added 11.99%	47,104 $6.08 Million
Q3 2018 Nov 13, 2018	BUY	$121.58 - $142.88 $104,801 - $123,162	862 Added 2.09%	42,060 $5.81 Million
Q2 2018 Aug 07, 2018	BUY	$119.4 - $131.76 $75,580 - $83,404	633 Added 1.56%	41,198 $5 Million
Q1 2018 May 14, 2018	SELL	$125.1 - $148.14 $166,132 - $196,729	-1,328 Reduced 3.17%	40,565 $5.2 Million
Q4 2017 Feb 09, 2018	SELL	$131.22 - $143.62 $2.96 Million - $3.24 Million	-22,548 Reduced 34.99%	41,893 $5.85 Million
Q3 2017 Nov 09, 2017	BUY	$129.47 - $135.38 $8.34 Million - $8.72 Million	64,441	64,441 $8.38 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $376B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.

Account

Clearstead Advisors, LLC Johnson & Johnson Transaction History